# Pamlico BioPharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pamlico-biopharma

- Industry: Biotechnology
- Headquarters: Oklahoma City, US
- Website: pamlicobio.com
- Total disclosed funding: $2.2M
- Latest round: Series A (Apr 29, 2015)
- Investors on record: 2

## About

Pamlico BioPharma, Inc. is based in the US and develops human monoclonal antibody therapeutics for the treatment of human pathogens, cancer, and autoimmune diseases.

## Funding rounds

- Series A, Apr 29, 2015, $2.2M — Oklahoma Seed Capital Fund, Accele Biopharma

## Investors

- Oklahoma Seed Capital Fund — Series A
- Accele Biopharma (https://capitalatlas.ai/funds/accele-biopharma) — Series A